AskBio Receives European Commission Orphan Drug Designation through its EU-Based subsidiary BrainVectis for AB-1003, a Novel Investigational AAV Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy (LGMD)
(Adnkronos) – — LGMD is a Rare Form of Muscular Dystrophy with No Approved Therapy — RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2023 /PRNewswire/ — Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and
